Jieyi Ma
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- RNA and protein synthesis mechanisms
Papers in
-
- RNA modifications and cancer 15
- Cancer-related gene regulation 10
- RNA Research and Splicing 8
- Circular RNAs in diseases 5
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Hui Han (12 shared papers)Chunlong Yang (9 shared papers)Wenjian Wang (7 shared papers)Shuibin Lin (11 shared papers)Jiong Bi (7 shared papers)Siyi Zheng (9 shared papers)Shenming Wang (6 shared papers)Guangqi Chang (5 shared papers)
- Journals
- Journal of Clinical Investigation (3 papers)Cell Reports (2 papers)BMC Cancer (2 papers)Oncogene (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Jieyi Ma
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 656
- Molecular Biology 1.1k
- Oncology 171
- Transplantation 10
- Pulmonary and Respiratory Medicine 117
Countries citing papers authored by Jieyi Ma
This map shows the geographic impact of Jieyi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieyi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieyi Ma more than expected).
Fields of papers citing papers by Jieyi Ma
This network shows the impact of papers produced by Jieyi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieyi Ma. The network helps show where Jieyi Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Jieyi Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 189 | |
| 2 | 2014 | 162 | |
| 3 | 2022 | 125 | |
| 4 | 2022 | 95 | |
| 5 | 2017 | 91 | |
| 6 | 2020 | 55 | |
| 7 | 2021 | 52 | |
| 8 | 2015 | 49 | |
| 9 | 2021 | 45 | |
| 10 | 2023 | 43 | |
| 11 | 2017 | 40 | |
| 12 | 2023 | 33 | |
| 13 | 2020 | 33 | |
| 14 | 2017 | 28 | |
| 15 | 2017 | 24 | |
| 16 | 2015 | 22 | |
| 17 | 2022 | 21 | |
| 18 | 2018 | 20 | |
| 19 | Specific and nonspecific monoclonal 125I-Incstar assays. | 1990 | 20 |
| 20 | 2018 | 19 |
About Jieyi Ma
Jieyi Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Epidemiology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (11 papers), Cancer-related gene regulation (10 papers), RNA Research and Splicing (8 papers), MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Cancer Research (656 citations), Molecular Biology (1.1k citations), Oncology (171 citations), Transplantation (10 citations) and Pulmonary and Respiratory Medicine (117 citations). Jieyi Ma has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Hui Han, Chunlong Yang, Wenjian Wang, Shuibin Lin, Jiong Bi, Siyi Zheng, Shenming Wang, Guangqi Chang, Lu Wang and Siyao Guo. Their work appears in journals such as Journal of Clinical Investigation, Cell Reports, BMC Cancer, Oncogene and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.